Balance Sheet Immatics N.V.

Stocks

IMTX

NL0015285941

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 01:30:00 11/06/2026 am IST			5-day change	1st Jan Change
8.870 ^USD	-3.17%		-13.08%	-15.52%

01/06	Immatics Presents Clinical Activity and Response Dynamics of Anzu-Cel Prame Cell Therapy At 2026 Asco Annual Meeting	CI
31/05	Immatics N.V. Presents Data on IMA401 MAGEA4/8 Bispecific at 2026 ASCO Annual Meeting with Simultaneous Publication in Nature Medicine Supporting Development of IMA401/IMA402 Combination in Lung Cancer	CI

865b843c98a9f0509179.0zM7OuItpnzfVQJzswGgsdHh4b8mwv-weaFdMWPe9ok.kXtxX7pZ8TWZY0AV_VTm_IiHtvBx9Yf_Pu8TAA23vuOja35ZmEn0H71ndQ

Published financial data: IMMATICS N.V.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	3.48Cr	17Cr	5.4Cr	16Cr	4.83Cr
Total Revenues	3.48Cr	17Cr	5.4Cr	16Cr	4.83Cr
Cost of Goods Sold, Total	8.76Cr	11Cr	12Cr	15Cr	18Cr
Gross Profit	-5.28Cr	6.61Cr	-6.47Cr	77.56L	-14Cr
Selling General & Admin Expenses, Total	3.38Cr	3.61Cr	3.82Cr	4.64Cr	5.12Cr
Other Operating Expenses	-3L	-26T	-11.39L	-78T	-47.34L
Other Operating Expenses, Total	3.35Cr	3.61Cr	3.71Cr	4.64Cr	4.64Cr
Operating Income	-8.63Cr	3Cr	-10Cr	-3.86Cr	-18Cr
Interest Expense, Total	-6L	-10.38L	-8L	-9L	-9L
Interest And Investment Income	1L	24.76L	1.38Cr	2.5Cr	1.72Cr
Net Interest Expenses	-4L	14.38L	1.3Cr	2.41Cr	1.62Cr
Currency Exchange Gains (Loss)	52.66L	4L	-56.28L	1.84Cr	-3.53Cr
Other Non Operating Income (Expenses)	-1.19Cr	1.02Cr	-26.55L	1.75Cr	26.21L
EBT, Excl. Unusual Items	-9.33Cr	4.2Cr	-9.7Cr	2.13Cr	-20Cr
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	-9.33Cr	4.2Cr	-9.7Cr	2.13Cr	-20Cr
Income Tax Expense	-	45.22L	-	61.28L	-19.89L
Earnings From Continuing Operations	-9.33Cr	3.75Cr	-9.7Cr	1.52Cr	-20Cr
Net Income to Company	-9.33Cr	3.75Cr	-9.7Cr	1.52Cr	-20Cr
Minority Interest	-	-	-	-	-
Net Income - (IS)	-9.33Cr	3.75Cr	-9.7Cr	1.52Cr	-20Cr
Net Income to Common Incl Extra Items	-9.33Cr	3.75Cr	-9.7Cr	1.52Cr	-20Cr
Net Income to Common Excl. Extra Items	-9.33Cr	3.75Cr	-9.7Cr	1.52Cr	-20Cr
Per Share Items
Net EPS - Basic	-1.48	0.56	-1.2	0.14	-1.61
Basic EPS - Continuing Operations	-1.48	0.56	-1.2	0.14	-1.61
Basic Weighted Average Shares Outstanding	6.29Cr	6.72Cr	8.05Cr	11Cr	12Cr
Net EPS - Diluted	-1.48	0.55	-1.2	0.14	-1.61
Diluted EPS - Continuing Operations	-1.48	0.55	-1.2	0.14	-1.61
Diluted Weighted Average Shares Outstanding	6.29Cr	6.88Cr	8.05Cr	11Cr	12Cr
Normalized Basic EPS	-0.93	0.39	-0.75	0.13	-1.01
Normalized Diluted EPS	-0.93	0.38	-0.75	0.12	-1.01
Supplemental Items
EBITDA	-8.37Cr	3.31Cr	-9.84Cr	-2.99Cr	-17Cr
EBITA	-8.62Cr	3Cr	-10Cr	-3.85Cr	-18Cr
EBIT	-8.63Cr	3Cr	-10Cr	-3.86Cr	-18Cr
EBITDAR	-8.36Cr	3.33Cr	-	-2.98Cr	-17Cr
Effective Tax Rate - (Ratio)	-	10.76	-	28.71	1
Total Current Taxes	-	45.22L	-	77.9L	9T
Total Deferred Taxes	-	-	-	-16.62L	-19.98L
Normalized Net Income	-5.83Cr	2.63Cr	-6.06Cr	1.33Cr	-12Cr
Interest on Long-Term Debt	6L	10.38L	8L	9L	9L
Supplemental Operating Expense Items
General and Administrative Expenses	3.37Cr	3.59Cr	3.82Cr	4.64Cr	5.12Cr
Research And Development Expense From Footnotes	8.76Cr	11Cr	12Cr	15Cr	18Cr
Net Rental Expense, Total	95T	2L	-	85T	1L
Imputed Operating Lease Interest Expense	53.64T	1L	-	38.13T	51.82T
Imputed Operating Lease Depreciation	41.36T	60.76T	-	46.87T	57.18T
Stock-Based Comp., COGS (Total)	1.56Cr	1.29Cr	1.2Cr	95.87L	75.38L
Stock-Based Comp., G&A Exp. (Total)	1.08Cr	96.45L	87.33L	80.55L	74.77L
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	2.64Cr	2.26Cr	2.07Cr	1.76Cr	1.5Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	13Cr	15Cr	22Cr	24Cr	35Cr
Short Term Investments	1.21Cr	21Cr	21Cr	37Cr	12Cr
Total Cash And Short Term Investments	15Cr	36Cr	43Cr	60Cr	47Cr
Accounts Receivable, Total	7L	11.11L	40.93L	58.57L	60.99L
Other Receivables	16.77L	10.31L	16.44L	9L	8L
Total Receivables	23.59L	21.42L	57.37L	67.45L	68.81L
Prepaid Expenses	37.81L	1.04Cr	1.06Cr	1.2Cr	1.29Cr
Other Current Assets, Total	10L	23.57L	71.19L	63.1L	1.49Cr
Total Current Assets	15Cr	38Cr	45Cr	63Cr	50Cr
Gross Property Plant And Equipment	3.77Cr	4.7Cr	7.99Cr	9.58Cr	8.47Cr
Accumulated Depreciation	-1.73Cr	-2.05Cr	-2.29Cr	-3.21Cr	-2.98Cr
Net Property Plant And Equipment	2.05Cr	2.65Cr	5.71Cr	6.37Cr	5.49Cr
Other Intangibles, Total	13.15L	16.32L	15.23L	16.29L	15.82L
Other Long-Term Assets, Total	6L	25.45L	20.17L	12.5L	18.5L
Total Assets	17Cr	41Cr	51Cr	70Cr	56Cr
Liabilities
Accounts Payable, Total	1.16Cr	40.25L	76.66L	1.01Cr	3L
Accrued Expenses, Total	23.67L	1.39Cr	2.24Cr	1.42Cr	2.25Cr
Current Portion of Leases	27.11L	21.59L	26.04L	28.51L	27.57L
Current Income Taxes Payable	-	42.98L	42.98L	17.61L	32T
Unearned Revenue Current, Total	5.04Cr	6.5Cr	10Cr	3.59Cr	1.58Cr
Other Current Liabilities	2.8Cr	1.71Cr	1.92Cr	31.87L	15.5L
Total Current Liabilities	9.51Cr	11Cr	16Cr	6.8Cr	4.3Cr
Long-Term Leases	71.42L	1.24Cr	1.28Cr	1.34Cr	1.29Cr
Unearned Revenue Non Current	4.82Cr	7.58Cr	12Cr	3.42Cr	1.85Cr
Deferred Tax Liability Non Current	-	-	-	58.04L	38.07L
Other Non Current Liabilities	68T	42T	4T	-	-
Total Liabilities	15Cr	19Cr	28Cr	12Cr	7.82Cr
Common Stock, Total	6L	8L	8L	12.16L	13.41L
Additional Paid In Capital	57Cr	71Cr	82Cr	116.21Cr	127.73Cr
Retained Earnings	-54Cr	-50Cr	-60Cr	-59Cr	-79Cr
Comprehensive Income and Other	-39.45L	-14.81L	-16.36L	10.31L	-85.92L
Total Common Equity	2.41Cr	21Cr	23Cr	57Cr	48Cr
Minority Interest	-	-	-	-	-
Total Equity	2.41Cr	21Cr	23Cr	57Cr	48Cr
Total Liabilities And Equity	17Cr	41Cr	51Cr	70Cr	56Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	6.29Cr	7.67Cr	10Cr	12Cr	13Cr
ECS Total Common Shares Outstanding	6.29Cr	7.67Cr	8.47Cr	12Cr	13Cr
Book Value / Share	0.38	2.78	2.66	4.73	3.61
Tangible Book Value	2.27Cr	21Cr	22Cr	57Cr	48Cr
Tangible Book Value Per Share	0.36	2.76	2.64	4.72	3.6
Total Debt	98.53L	1.46Cr	1.54Cr	1.62Cr	1.56Cr
Net Debt	-14Cr	-35Cr	-41Cr	-59Cr	-45Cr
Debt Equivalent Oper. Leases	8L	15.2L	-	7L	9L
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	2.78Cr	3.39Cr	6.66Cr	5.1Cr	4.31Cr
Full Time Employees	314	358	432	554	589
Part Time Employees	67	84	103	128	122

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-9.33Cr	3.75Cr	-9.7Cr	1.52Cr	-20Cr
Depreciation & Amortization - CF	51L	67.49L	70.11L	1.2Cr	1.23Cr
Amortization of Goodwill and Intangible Assets - (CF)	54T	60T	85T	1L	1L
Depreciation & Amortization, Total	51.54L	68.09L	70.96L	1.21Cr	1.24Cr
Amortization of Deferred Charges, Total - (CF)	1L	2L	1L	78T	28T
(Gain) Loss From Sale Of Asset	-	-	-2L	1T	8L
Stock-Based Compensation (CF)	2.64Cr	2.26Cr	2.07Cr	1.76Cr	1.5Cr
Other Operating Activities, Total	1.16Cr	-41.78L	58.03L	-3.92Cr	3.56Cr
Change In Accounts Receivable	6L	-4L	-29.82L	-17.64L	-2L
Change In Accounts Payable	-3.18Cr	4.56Cr	8.6Cr	-16Cr	-3.76Cr
Change in Other Net Operating Assets	-5L	-78.72L	-13.87L	-20.61L	-61.08L
Cash from Operations	-8.18Cr	10Cr	1.82Cr	-16Cr	-18Cr
Capital Expenditure	-51.06L	-57.38L	-3.08Cr	-1.63Cr	-65.58L
Sale of Property, Plant, and Equipment	-	52T	2L	2T	-
Sale (Purchase) of Intangible assets	-6L	-5L	-2L	-2L	-2L
Investment in Marketable and Equity Securities, Total	1.32Cr	-20Cr	-6L	-14Cr	21Cr
Cash from Investing	74.93L	-21Cr	-3.14Cr	-15Cr	20Cr
Long-Term Debt Repaid, Total	-27.07L	-28.43L	-38.49L	-20.12L	-29.59L
Total Debt Repaid	-27.07L	-28.43L	-38.49L	-20.12L	-29.59L
Issuance of Common Stock	94T	13Cr	9.04Cr	34Cr	11Cr
Other Financing Activities, Total	-	-79.31L	-20.39L	-2.13Cr	-69.98L
Cash from Financing	-26.13L	12Cr	8.45Cr	32Cr	9.74Cr
Foreign Exchange Rate Adjustments	23.68L	14.75L	-14.03L	90.09L	-1.63Cr
Net Change in Cash	-7.45Cr	1.55Cr	7Cr	1.83Cr	11Cr
Supplemental Items
Cash Interest Paid	6L	7L	3L	9L	9L
Cash Income Tax Paid (Refund)	-	2L	-	-	44.3L
Levered Free Cash Flow	-1.15Cr	4.54Cr	-2.6Cr	-10Cr	-13Cr
Unlevered Free Cash Flow	-1.12Cr	4.6Cr	-2.55Cr	-10Cr	-13Cr
Change In Net Working Capital	-1.68Cr	-39.97L	-4.11Cr	9.04Cr	3.44Cr
Net Debt Issued / Repaid	-27.07L	-28.43L	-38.49L	-20.12L	-29.59L

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-25.13	6.43	-13.85	-4	-18.08
Return on Total Capital	-84.61	14.31	-27.16	-5.86	-20.86
Return On Equity %	-167.49	31.63	-44.26	3.84	-37.1
Return on Common Equity	-167.49	31.63	-44.26	3.84	-37.1
Margin Analysis
Gross Profit Margin %	-151.92	38.22	-119.76	4.98	-280.87
SG&A Margin	97.25	20.9	70.74	29.81	106.05
EBITDA Margin %	-240.68	19.18	-182.14	-19.18	-358.17
EBITA Margin %	-248.08	17.37	-188.23	-24.71	-376.88
EBIT Margin %	-248.24	17.33	-188.39	-24.78	-377.11
Income From Continuing Operations Margin %	-268.49	21.71	-179.63	9.77	-407.01
Net Income Margin %	-268.49	21.71	-179.63	9.77	-407.01
Net Avail. For Common Margin %	-268.49	21.71	-179.63	9.77	-407.01
Normalized Net Income Margin	-167.81	15.2	-112.27	8.56	-256.96
Levered Free Cash Flow Margin	-33.13	26.26	-48.13	-65.29	-265.59
Unlevered Free Cash Flow Margin	-32.12	26.64	-47.16	-64.93	-264.37
Asset Turnover
Asset Turnover	0.16	0.59	0.12	0.26	0.08
Fixed Assets Turnover	2.01	7.36	1.29	2.58	0.81
Receivables Turnover (Average Receivables)	35.99	192.78	20.75	31.32	8.07
Short Term Liquidity
Current Ratio	1.6	3.54	2.87	9.26	11.72
Quick Ratio	1.55	3.42	2.76	8.99	11.07
Operating Cash Flow to Current Liabilities	-0.86	0.94	0.12	-2.32	-4.11
Days Sales Outstanding (Average Receivables)	10.14	1.89	17.59	11.68	45.21
Average Days Payable Outstanding	45.17	12.02	17.98	21.97	10.38
Long Term Solvency
Total Debt/Equity	40.95	6.83	6.84	2.82	3.23
Total Debt / Total Capital	29.05	6.39	6.4	2.74	3.13
LT Debt/Equity	29.68	5.82	5.69	2.32	2.66
Long-Term Debt / Total Capital	21.06	5.45	5.32	2.26	2.58
Total Liabilities / Total Assets	86.22	47.73	55.86	17.42	13.91
EBIT / Interest Expense	-152.46	28.86	-122.41	-43.58	-192.41
EBITDA / Interest Expense	-143.36	35.42	-113.87	-29.87	-179.33
(EBITDA - Capex) / Interest Expense	-152.38	29.89	-150.94	-48.24	-186.26
Total Debt / EBITDA	-0.12	0.4	-0.16	-0.61	-0.09
Net Debt / EBITDA	1.67	-9.46	4.34	22.22	2.67
Total Debt / (EBITDA - Capex)	-0.11	0.47	-0.12	-0.38	-0.09
Net Debt / (EBITDA - Capex)	1.57	-11.21	3.27	13.76	2.57
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	11.23	397.17	-68.76	188.6	-69.03
Gross Profit, 1 Yr. Growth %	47.38	-225.07	-197.9	-111.99	-1.85T
EBITDA, 1 Yr. Growth %	23.84	-139.61	-396.75	-69.61	478.47
EBITA, 1 Yr. Growth %	23.8	-134.8	-438.64	-62.11	372.35
EBIT, 1 Yr. Growth %	23.78	-134.71	-439.6	-62.04	371.36
Earnings From Cont. Operations, 1 Yr. Growth %	-55.94	-140.19	-358.55	-116.08	-1.39T
Net Income, 1 Yr. Growth %	-55.82	-140.19	-358.55	-116.08	-1.39T
Normalized Net Income, 1 Yr. Growth %	60.47	-145.04	-330.74	-122.01	-1.03T
Diluted EPS Before Extra, 1 Yr. Growth %	-66.3	-137.07	-318.95	-111.86	-1.25T
Accounts Receivable, 1 Yr. Growth %	-45.44	62.9	268.41	43.1	4.13
Net Property, Plant and Equip., 1 Yr. Growth %	46.17	29.29	115.39	11.67	-13.84
Total Assets, 1 Yr. Growth %	-31.42	133.51	25.05	36.51	-19.22
Tangible Book Value, 1 Yr. Growth %	-73.69	829.89	5.69	165.26	-15.82
Common Equity, 1 Yr. Growth %	-72.46	785.86	5.59	164.15	-15.79
Cash From Operations, 1 Yr. Growth %	-4.47	-218.15	-81.8	-966.96	11.77
Capital Expenditures, 1 Yr. Growth %	-31.19	12.38	436.75	-47.17	-59.7
Levered Free Cash Flow, 1 Yr. Growth %	-108.42	-494.07	-157.25	291.52	26
Unlevered Free Cash Flow, 1 Yr. Growth %	-108.15	-512.37	-155.31	297.33	26.1
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	37.27	135.16	24.63	-5.04	-5.46
Gross Profit, 2 Yr. CAGR %	56.21	35.77	10.66	-65.73	44.79
EBITDA, 2 Yr. CAGR %	69.4	-29.92	8.49	-5.27	32.67
EBITA, 2 Yr. CAGR %	61.9	-34.33	8.63	12.98	33.87
EBIT, 2 Yr. CAGR %	61.68	-34.45	8.57	13.54	33.76
Earnings From Cont. Operations, 2 Yr. CAGR %	69.5	-57.92	1.94	-25.88	44.07
Net Income, 2 Yr. CAGR %	71.94	-57.86	1.94	-25.88	44.07
Normalized Net Income, 2 Yr. CAGR %	73.46	-14.99	1.94	-28.74	43.03
Diluted EPS Before Extra, 2 Yr. CAGR %	24.7	-64.65	-9.91	-40.84	16.81
Accounts Receivable, 2 Yr. CAGR %	-15.58	-5.72	144.98	129.6	22.07
Net Property, Plant and Equip., 2 Yr. CAGR %	59.96	37.47	66.88	55.09	-1.91
Total Assets, 2 Yr. CAGR %	14.05	26.55	70.88	30.65	5.01
Tangible Book Value, 2 Yr. CAGR %	-27.15	56.4	213.49	68.57	49.43
Common Equity, 2 Yr. CAGR %	-24.18	56.18	205.84	68.13	49.15
Cash From Operations, 2 Yr. CAGR %	7.35	11.39	-53.62	25.63	211.28
Capital Expenditures, 2 Yr. CAGR %	54.36	-12.06	145.6	68.4	-53.86
Levered Free Cash Flow, 2 Yr. CAGR %	-27.88	-42.39	50.2	49.71	122.1
Unlevered Free Cash Flow, 2 Yr. CAGR %	-29.16	-42.02	51.03	48.25	123.84
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	109.7	110.81	19.99	64.89	-34.64
Gross Profit, 3 Yr. CAGR %	20.48	45.05	21.75	-47.24	27.08
EBITDA, 3 Yr. CAGR %	37.43	4.37	13.38	-29.02	73.15
EBITA, 3 Yr. CAGR %	35.99	-3.02	13.46	-23.53	82
EBIT, 3 Yr. CAGR %	35.86	-3.19	13.42	-23.51	82.48
Earnings From Cont. Operations, 3 Yr. CAGR %	42.35	4.91	-22.93	-45.37	92.12
Net Income, 3 Yr. CAGR %	43.72	5.92	-22.86	-45.37	92.12
Normalized Net Income, 3 Yr. CAGR %	44.56	10.66	18.59	-38.85	67.75
Diluted EPS Before Extra, 3 Yr. CAGR %	16.01	-16.77	-35.08	-54.47	59.07
Accounts Receivable, 3 Yr. CAGR %	20.17	5.1	48.49	104.78	76.41
Net Property, Plant and Equip., 3 Yr. CAGR %	72.28	49	59.67	45.96	27.5
Total Assets, 3 Yr. CAGR %	41.75	44.82	26.05	58.56	11.3
Tangible Book Value, 3 Yr. CAGR %	25.73	70.25	37.25	193.17	33.74
Common Equity, 3 Yr. CAGR %	32.23	72.05	37.08	188	33.52
Cash From Operations, 3 Yr. CAGR %	58.13	12.16	-39.1	23.09	20.83
Capital Expenditures, 3 Yr. CAGR %	128.32	38.86	60.71	47.16	4.55
Levered Free Cash Flow, 3 Yr. CAGR %	-	27.03	-42.51	106.71	41.35
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	27.43	-42.92	108.49	40.47
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	70.3	53.23	9.08
Gross Profit, 5 Yr. CAGR %	-	-	16.45	-18.55	30.49
EBITDA, 5 Yr. CAGR %	-	-	25	0.5	20.7
EBITA, 5 Yr. CAGR %	-	-	24.27	3.2	21.19
EBIT, 5 Yr. CAGR %	-	-	24.21	3.18	21.16
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	24.55	-14.07	-1.5
Net Income, 5 Yr. CAGR %	-	-	25.27	-13.58	-1.45
Normalized Net Income, 5 Yr. CAGR %	-	-	25.71	-7.2	27.82
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	4.85	-31.87	-18.22
Accounts Receivable, 5 Yr. CAGR %	-	-	59.78	43.67	37.3
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	70.1	51.41	31.4
Total Assets, 5 Yr. CAGR %	-	-	52.75	38.98	17.17
Tangible Book Value, 5 Yr. CAGR %	-	-	81.2	67.98	41.03
Common Equity, 5 Yr. CAGR %	-	-	84.93	68.87	40.83
Cash From Operations, 5 Yr. CAGR %	-	-	-2.5	17.36	16.96
Capital Expenditures, 5 Yr. CAGR %	-	-	135.08	50	-2.44
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	35.66	-1.29
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	35.38	-1.41